Physician profile
Rebecca Marcantuono
NPI 1689925067
$17,458.67
in general payments reported to CMS, 2019-2025
14 companies · $6,908 in 2025
The $6,908 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $587 · 2022: $3,102 · 2023: $1,100 · 2024: $5,761 · 2025: $6,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,185 · Travel and Lodging: $4,458 · Consulting Fee: $2,125 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,185.08 |
| Travel and Lodging | $4,458.23 |
| Consulting Fee | $2,125.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,569.41 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $5,831.33 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $814.45 | 2022-2025 | Mitraclip, Triclip, Navitor |
| Novartis Pharmaceuticals Corporation | $520.66 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $179.39 | 2022-2024 | Xarelto |
| Philips North America LLC | $173.08 | 2023-2024 | (Ck4) Mcot |
| Amgen INC. | $130.71 | 2021-2025 | Repatha |
| Atricure, INC. | $78.74 | 2022 | |
| Boston Scientific Corporation | $35.41 | 2021 | |
| Janssen Scientific Affairs, LLC | $32.59 | 2023 | Xarelto |
| Heartflow, INC. | $23.41 | 2025 | |
| Novo Nordisk INC | $23.23 | 2025 | Wegovy |
| W. L. Gore & Associates, INC. | $23.15 | 2023 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals International, Plc | $23.11 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Marcantuono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.